NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-178-2008-3-PCT-01 MOLECULAR SCAFFOLDS FOR HIV-1 EPITOPES PCT PCT COMB PCT/US2005/011928 Expired
NIAID E-022-2008-1-US-01 Molecular Scaffolds For HIV-1 Immunogens US 60/669,612 Abandoned
NCI E-128-2005-0-US-01 Human Artificial Chromosome With A Predetermined Sequence For Gene Delivery And Gene Targeting US 60/669,589 Abandoned
NIAID E-043-2005-0-US-01 A Method For Generation Of Cells Expressing Self-replicating Norovirus RNA (norovirus "replicons") US 60/669,817 Abandoned
NIMH E-169-2004-0-PCT-02 Reporter Plasmid Phage Packaging System For Detection Of Bacteria PCT PCT PCT/US2005/011607 Expired
NIMH E-169-2004-0-CA-04 Reporter Plasmid Phage Packaging System For Detection Of Bacteria CA National Stage 2562457 Abandoned
NIMH E-169-2004-0-AU-05 Reporter Plasmid Phage Packaging System For Detection Of Bacteria AU National Stage 2005324479 Abandoned
NHGRI E-027-2004-0-US-03 Rapid Integration Site Mapping US ORD 11/101,299 Abandoned
NIAID E-165-2004-0-PCT-02 SARS Coronavirus MVA Vaccines And Therapy PCT PCT PCT/US2005/011510 Abandoned
NCI E-275-2002-1-SE-16 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy SE EP 03794636.5 Expired
NCI E-275-2002-1-CH-07 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy CH EP 03794636.5 Expired
NCI E-275-2002-1-ES-10 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy ES EP 03794636.5 Expired
NCI E-275-2002-1-GB-12 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy GB EP 03794636.5 Expired
NCI E-275-2002-1-FR-11 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy FR EP 03794636.5 Expired
NCI E-275-2002-1-DK-09 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy DK EP 03794636.5 Expired
NCI E-275-2002-1-DE-08 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy DE EP 03794636.5 Expired
NCI E-275-2002-1-NO-15 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy NO EP 03794636.5 Expired
NCI E-275-2002-1-NL-14 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy NL EP 03794636.5 Expired
NCI E-275-2002-1-IT-13 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy IT EP 03794636.5 Expired
NIMH E-247-2002-1-US-02 METHODS AND FORMULATIONS COMPRISING AGONISTS AND ANTAGONISTS OF NUCLEAR HORMONE RECEPTORS US ORD 10/530,254 Abandoned
NICHD E-145-2005-0-CN-02 Generation Of Tri-functional Nanopsheres For Biotargeting, Purification CN ORD 200510079227.0 Abandoned
NCI E-167-2007-0-KR-09 Antigenic Peptides KR National Stage 10-2005-7005874 Abandoned
NINDS E-001-2003-1-US-02 METHODS FOR CONTROLLING PROLIFERATION OF CELLS US National Stage 10/530,340 Abandoned
NCI E-167-2007-0-JP-08 Antigenic Peptides JP National Stage 2004-541361 Abandoned
NCI E-306-2000-0-JP-04 CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHODS OF MAKING SAME. JP National Stage 2004-525993 Abandoned
NIAID E-164-2005-0-US-01 Method For Improving The Immune Response To DNA Vaccines To West Nile Virus (WNV) And Other Disease Targets Using Alternate Promoters US 60/667,064 Abandoned
NCI E-273-2002-0-US-02 NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE US DIV 11/096,924 7863262 Expired PDF
NIAID E-178-1999-1-US-02 Production Of Attenuated, Human-Bovine Chimeric Respiratory Syncytial Virus Vaccines US CON 11/097,946 7829102 Abandoned PDF
NICHD E-061-2005-0-PCT-02 A Novel Marker For Cardiomyocyte Progenitor Cells PCT PCT PCT/US2005/010611 Expired
NICHD E-061-2005-0-US-03 A Novel Marker For Cardiomyocyte Progenitor Cells US National Stage 11/918,678 Abandoned
NCI E-018-2005-1-US-01 Method of Diagnosing and Treating Cancer Using Beta-Catenin Splice Variants US 60/667,084 Abandoned
NCI E-030-2004-0-EP-06 SCHWEINFURTHIN ANALOGUES EP National Stage 05760943.0 Expired
NCI E-030-2004-0-US-03 Novel Schweinfurthin Analogs As Anticancer Agents US ORD 11/093,270 7358377 Abandoned PDF
NCI E-030-2004-0-PCT-02 Novel Schweinfurthin Analogs As Anticancer Agents PCT PCT PCT/US2005/010482 Expired
NCI E-030-2004-0-AU-05 Novel Schweinfurthin Analogs As Anticancer Agents AU National Stage 2005227328 Abandoned
NCI E-030-2004-0-CA-04 Novel Schweinfurthin Analogs As Anticancer Agents CA National Stage 2560557 Abandoned
NINDS E-181-2002-0-JP-07 Methods and Devices for Intramuscular Stimulation of Upper Airway and Swallowing Muscle Groups JP National Stage 2004-540204 Abandoned
NCI E-260-1994-1-US-04 A METHOD OF ENHANCING A TARGETED IMMUNE RESPONSE AGAINST TUMORS US CON 11/090,686 7368116 Expired PDF
NIAMS E-011-2005-0-US-11 Cross-linked Polymer Matrices, And Methods Of Making And Using Same US National Stage 11/090,362 Abandoned
NCI E-235-2004-0-US-01 Inhibition Of SMAD-signaling Leads To Enhanced Insulin Production And Better Glucose Control A Potential Therapy For Diabetes And Associated Complications Due To Hyperglycemina US 60/665,204 Abandoned
NINDS E-202-2002-0-IT-12 METHOD FOR CONVECTION ENHANCED DELIVERY OF THERAPEUTIC AGENTS IT EP 03756863.1 Expired
NINDS E-202-2002-0-GB-10 METHOD FOR CONVECTION ENHANCED DELIVERY OF THERAPEUTIC AGENTS GB EP 03756863.1 Expired
NINDS E-202-2002-0-ES-11 METHOD FOR CONVECTION ENHANCED DELIVERY OF THERAPEUTIC AGENTS ES EP 03756863.1 Expired
NINDS E-202-2002-0-FR-09 METHOD FOR CONVECTION ENHANCED DELIVERY OF THERAPEUTIC AGENTS FR EP 03756863.1 Expired
NINDS E-202-2002-0-DE-08 METHOD FOR CONVECTION ENHANCED DELIVERY OF THERAPEUTIC AGENTS DE EP 03756863.1 Expired
NCI E-294-2002-0-US-03 Compositions and Methods for Promoting Angiogenesis US National Stage 10/529,116 7462593 Abandoned PDF
NCI E-293-2002-0-US-03 VASOREGULATING COMPOUNDS AND METHODS OF THEIR USE US National Stage 10/529,118 7364719 Abandoned PDF
NHLBI E-008-2005-0-US-02 Method Of Identifiying Active Chromatin Domains US ORD 11/087,896 7527970 Expired PDF
NIDDK E-148-2008-0-US-02 Compositions And Methods For Inhibiting Mucin-type O-linked Glycosylation US ORD 11/088,546 Abandoned
NCI E-072-2005-0-US-01 Inhiibtion of Proteasome Function to Potentiate the Proapoptotic and Antitumor Activity of Cytokines US 60/665,167 Abandoned